WO2004089907A1 - キノリン化合物の製造方法 - Google Patents
キノリン化合物の製造方法 Download PDFInfo
- Publication number
- WO2004089907A1 WO2004089907A1 PCT/JP2004/002464 JP2004002464W WO2004089907A1 WO 2004089907 A1 WO2004089907 A1 WO 2004089907A1 JP 2004002464 W JP2004002464 W JP 2004002464W WO 2004089907 A1 WO2004089907 A1 WO 2004089907A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- quinoline
- substituent
- compound
- iii
- Prior art date
Links
- -1 quinoline compound Chemical class 0.000 title abstract description 32
- 238000000034 method Methods 0.000 title abstract description 23
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title abstract description 19
- WRXZCLBKDXISQA-UHFFFAOYSA-N 2-chloro-7-methoxyquinoline-3-carbaldehyde Chemical compound C1=C(C=O)C(Cl)=NC2=CC(OC)=CC=C21 WRXZCLBKDXISQA-UHFFFAOYSA-N 0.000 claims abstract description 28
- 150000002466 imines Chemical class 0.000 claims abstract description 27
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 4
- 125000001424 substituent group Chemical group 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 239000003905 agrochemical Substances 0.000 abstract description 2
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 description 20
- 239000000203 mixture Substances 0.000 description 18
- 239000002904 solvent Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229910052731 fluorine Inorganic materials 0.000 description 8
- 125000001153 fluoro group Chemical group F* 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- RPVBCVQKDPOMII-UHFFFAOYSA-N n-tert-butylethanimine Chemical compound CC=NC(C)(C)C RPVBCVQKDPOMII-UHFFFAOYSA-N 0.000 description 5
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052987 metal hydride Inorganic materials 0.000 description 4
- 150000004681 metal hydrides Chemical class 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- 150000003248 quinolines Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000010813 internal standard method Methods 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- WPYJKGWLDJECQD-UHFFFAOYSA-N quinoline-2-carbaldehyde Chemical compound C1=CC=CC2=NC(C=O)=CC=C21 WPYJKGWLDJECQD-UHFFFAOYSA-N 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 2
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- NKGJJLDEORZFKJ-UHFFFAOYSA-N n-butylethanimine Chemical compound CCCCN=CC NKGJJLDEORZFKJ-UHFFFAOYSA-N 0.000 description 2
- QWMYJOXBVBZDJM-UHFFFAOYSA-N n-cyclohexylethanimine Chemical compound CC=NC1CCCCC1 QWMYJOXBVBZDJM-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical group OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000587155 Athene Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000004791 alkyl magnesium halides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- BLHLJVCOVBYQQS-UHFFFAOYSA-N ethyllithium Chemical compound [Li]CC BLHLJVCOVBYQQS-UHFFFAOYSA-N 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GHZKGHQGPXBWSN-UHFFFAOYSA-N methyl(propan-2-yloxy)phosphinic acid Chemical compound CC(C)OP(C)(O)=O GHZKGHQGPXBWSN-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MXOWOGWCSFJPNN-UHFFFAOYSA-N n-propan-2-ylethanimine Chemical compound CC=NC(C)C MXOWOGWCSFJPNN-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002900 organolithium compounds Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- KJSVAZNPHAQRIM-UHFFFAOYSA-N phenol;prop-1-ene Chemical compound CC=C.OC1=CC=CC=C1 KJSVAZNPHAQRIM-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
Definitions
- the present invention relates to a method for producing a quinoline compound represented by the following general formula (I).
- the quinoline compound obtained by the present invention is a medicine. It is useful as a synthetic intermediate for pesticides and the like, for example, (E) -3- (4,1- (4,1,1-fluorophenylinole) -12, -cyclopropylquinolin-13,1-yl) propene Aldehyde is an intermediate in the synthesis of quinoline compounds known as inhibitors of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis.
- the organotin compound to be used is industrially difficult to obtain, and the reaction must be carried out at an extremely low temperature of 168 ° C., which requires special reaction equipment. I do.
- the above method (2) it is difficult to use a metal hydride used for reducing the ester moiety.
- the above methods (2) and (3) need to go through a number of steps to obtain the desired product. Therefore, all of these methods can be used for (E)-3-(4,-1 (4 "-phenololenophenyl)-1,-cyclopropinolequinolin-1-3,-inole) It is hard to say that it is an industrially advantageous method for producing quinoline compounds.
- an object of the present invention is to provide a method for efficiently and industrially producing a quinoline compound in a short process, using a raw material that is industrially easily available and easy to handle. It is in.
- RR 2, R 3, R 4, R 5 and R 6 are each a hydrogen atom, a halogen atom, a hydroxyl group which may be protected, an alkyl group which may have a substituent, a substituent Represents an aryl group which may have a substituent, an aralkyl group which may have a substituent, an alkoxyl group which may have a substituent or an aryloxy group which may have a substituent .
- quinoline carbaldehyde (II) is represented by the general formula (III) R '
- R 7 represents an alkyl group which may have a substituent.
- an imine compound (III) is reacted with an imine compound represented by the following formula [hereinafter referred to as an imine compound (III)], and then hydrolyzed:
- RR 2 , R 3 and R 6 described above are a hydrogen atom
- R 4 is a halogen atom
- R 5 is an alkyl group having 1 to 6 carbon atoms.
- RR 2 , R 3, and R 6 are a hydrogen atom
- R 4 is a fluorine atom
- R 5 is an alkyl group having 1 to 6 carbon atoms.
- the above-mentioned 1 , R 2 , R 3 and R 6 are a hydrogen atom, R 4 is a fluorine atom, and R 5 is an isopropyl group or a cyclopropyl group.
- examples of the halogen atom represented by 1 , R 2 , R 3 , R 4 , R 5, and R 6 include, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, and among them, a fluorine atom Is preferred.
- the hydroxyl groups represented by Ri, R 2 , R 3 , R 4 , R 5 and Re may be protected, and the protecting groups for the hydroxyl groups may be any protecting groups that are commonly used for protecting hydroxyl groups.
- an aralkyl group such as a benzyl group
- a trisubstituted silyl group such as a trimethylsilyl group, a tert-butyldimethylsilinole group, a tert-butyldiphenylsilinole group
- a methoxymethyl group a 1-ethoxyxyl group
- examples include ether-type protecting groups such as a tetrahydrofuranyl group and a tetrahydrovinyl group.
- the alkyl group represented by R1, R2, R3, R4, R5, R6 and may be any of linear, branched or cyclic.
- a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, n —Pentyl, n-hexyl, cyclopropyl, cyclohexyl and the like.
- These alkyl groups may have a substituent.
- Examples of such a substituent include a hydroxyl group; an alkoxyl group having preferably 1 to 4 carbon atoms such as a methoxy group, an ethoxy group, a propoxy group and a butoxy group.
- the aryl group represented by 1, R2, R3, R4, R5, and R6 preferably includes an aryl group having 6 to 10 carbon atoms, such as a phenyl group and a naphthyl group.
- the aralkyl groups represented by Ri, RR 3 , R 4 , R 5 and: 6 each preferably have an alkyl group having 1 to 6 carbon atoms, and the aryl group preferably has 6 to 1 carbon atoms.
- An aralkyl group having an aryl group of 0 is exemplified, and examples thereof include a benzyl group and a naphthylmethyl group. These aryl and aralkyl groups may have a substituent.
- Examples of such a substituent include a hydroxyl group; a methyl group, an ethyl group, an n-propyl group, an isopropylinole group, an n-butyl group, Isobutyl group, tert-butyl
- An alkyl group preferably having 1 to 6 carbon atoms, such as a group, n-pentyl group or n-hexyl group; preferably an alkyl group having 1 to 4 carbon atoms, such as a methoxy group, an ethoxy group, a propoxy group or a butoxy group.
- An alkoxyl group an aryl group having preferably 6 to 10 carbon atoms which may have a substituent such as a phenyl group, a p-methoxyphenyl group, or a p-chlorophenol group; a fluorine atom And a chlorine atom, a bromine atom and a halogen atom such as an iodine atom.
- R ⁇ R 2, R 3, R 4, R 5 and R 6 are the alkoxyl group represented respectively.
- Te are preferably include linear or branched alkoxyl group having 1-4 carbon atoms, e.g. Examples include a methoxy group, an ethoxy group, a propoxy group and a butoxy group. These alkoxyl groups may have a substituent.
- Examples of such a substituent include a hydroxyl group; an alkoxyl group having preferably 1 to 4 carbon atoms such as a methoxy group, an ethoxy group, a propoxy group and a butoxy group;
- a phenyl group, a p-methoxyphenyl group, a p-chloro phenyl group which may have a substituent, such as a phenyl group, is preferably an aryl group having 6 to 10 carbon atoms.
- the aryloxy group represented by R1, R2, R3, R4, R5 and R6 is preferably an aryloxy group having an aryl group preferably having 6 to 10 carbon atoms as the aryl moiety.
- Groups for example, a phenoxy group and a naphthyloxy group.
- These aryloxy groups may have a substituent, for example, a hydroxyl group; a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert- group.
- An alkyl group preferably having 1 to 6 carbon atoms such as a butyl group; an alkoxyl group preferably having 1 to 4 carbon atoms such as a methoxy group, an ethoxy group, a propoxy group and a butoxy group; a phenyl group and a p-methoxyphenol And an optionally substituted aryl group having 6 to 10 carbon atoms, such as a phenyl group.
- R i, RR 3 and R 6 are a hydrogen atom
- R 4 is a halogen atom
- R 5 is a C 1-6 carbon atom.
- Compounds that are alkyl groups are mentioned.
- quinoline carbaldehyde (II) and quinoline compound (I) more preferably 1 , RR 3 and R 6 are hydrogen atoms, R 4 is a fluorine atom, and R 5 is an isopropyl group or a cyclic propyl group. Certain compounds are mentioned.
- R7 is an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isoptyl group, a tert-butyl group, a pentyl pentyl group or a hexahexyl group. Certain compounds are mentioned. More preferably, the imine compound (III) is a compound in which is an isopropyl group, an n-butylinole group, an isoptinole group, an erptinoptinole group, or a cyclohexinole group.
- the process for producing the quinoline compound (I) of the present invention is carried out by reacting the quinoline carbaldehyde (II) with the imine compound (III), followed by hydrolysis.
- a quinoline compound (I) can be industrially advantageously produced in a short process and efficiently using raw materials that are industrially easily available and easy to handle.
- step 1 the step of reacting quinolincarbaldehyde (II) with the imine compound (III) [hereinafter referred to as step 1] will be described.
- a base is preferably present.
- the base include sodium metal carbonate, alkali metal carbonates such as carbon dioxide; sodium hydroxide, lithium hydroxide and the like.
- Metal hydrides such as lithium hydride, sodium hydride, hydrogen hydride and other metal hydrides; methyl lithium, ethyl lithium, n-butynolelithium, sec-butyl lithium, tert Organolithium compounds such as butyllithium and phenyllithium; alkylmagnesium halides such as methinolemagnesium chloride and ethinolemagnesium bromide; lithium amide, sodium amide, and power Lithium amide, lithium getyl amide, lithium di (isopropyl) amide, lithium bis (trimethylsilyl) amide, sodium bis (trimethylsilyl) amide, potassium bis (trimethylsilyl) amide, promoter magnesium Metal amides such as (isopropyl) amide; and metal amides such as
- sodium hydride, n-butyllithium, and lithium di (isopropyl) amide are preferably used from the viewpoints of availability, ease of handling, and reactivity.
- the amount of the base used is preferably in the range of 0.1 to 10 mole times the quinoline carboxaldehyde (II), and 0.1 to 5 times in terms of ease of post-treatment and economy. More preferably, it is in the molar range.
- Examples of the imine compound (III) used in step 1 include ethylidene isopropylamine, ethylidene II—butylamine, ethylidene isoptylamine, ethylidene tert—putinoleamine, and ethylidenecyclohexylamine.
- the amount of the imine compound (III) to be used is preferably in the range of 1.0 to 10 mol times the quinoline carbaldehyde (II), and from the viewpoint of ease of post-treatment and economical efficiency. More preferably, it is in the range of 0 to 5 moles.
- Step 1 is preferably performed in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction, and examples thereof include aliphatic hydrocarbons such as pentane, hexane, heptane, cyclohexane, and methylcyclohexane; and solvents such as benzene, toluene, and xylene.
- Aromatic hydrocarbons ; methanol, ethanol, isopropano, n-butano, tert-butano, etc .; Athenes such as ether / tetrahydrofuran and dioxane; nitrils such as benzo-tolyl; nitrogen-containing aromatic compounds such as pyridine; dimethylformamide, N-methylpyrrolidone, N, N, 1-dimethyli Amides such as midazolidinone and hexamethylphosphoric triamide Can be These solvents may be used alone or as a mixture of two or more.
- diisopropyl ether, tert-butyl methyl ether, and tetrahydrofuran are preferred from the viewpoints of easy handling, availability, and reactivity.
- the amount of the solvent used is preferably in the range of 1 to 50 times by mass relative to quinoline carbaldehyde (II), and more preferably in the range of 1 to 10 times by mass from the viewpoint of economy. preferable.
- the reaction temperature in step 1 varies depending on the type of quinoline carbaldehyde (II), the type of imine compound (III), the type of base, and the type of solvent to be used. It is preferably in the range of 0 ° C, more preferably in the range of 130 to 100 ° C.
- the reaction time of step 1 varies depending on the reaction temperature and the like, but is usually preferably in the range of 0.1 to 24 hours.
- the reaction is preferably performed in an atmosphere of an inert gas such as nitrogen, helium, or argon.
- step 1 There is no particular limitation on the operation method of step 1.
- a mixture of quinoline carboxaldehyde (II), imine compound (III) and a solvent under an atmosphere of an inert gas such as nitrogen, helium, or argon.
- an inert gas such as nitrogen, helium, or argon.
- the termination of the reaction in step 1 can be performed by, for example, adding water to the reaction system.
- the reaction in step 1 can be performed in either a batch system or a continuous system.
- the imine compound (III) used in step 1 such as ethylidene tert-butylamine can be easily produced by reacting tert-butylamine with acetoaldehyde (US Pat. No. 2,582,122). No. 8).
- the reaction mixture obtained in step 1 can be isolated and
- step 2 in a solvent containing water, for example, general hydrolysis conditions for reacting an acid can be applied.
- a solvent containing water for example, general hydrolysis conditions for reacting an acid.
- the amount of water used it is usually preferably at least 1 mol times the quinoline carbaldehyde (II) used in step 1, and more preferably in the range of 1 to 100 mol times. More preferred o
- examples of the acid include a mineral acid such as hydrochloric acid, sulfuric acid, and phosphoric acid; an organic acid such as acetic acid, propionic acid, oxalic acid, methanesulfonic acid, and toluenesulfonic acid; Japanese products or their salts.
- the amount of the acid used is not particularly limited, but is usually preferably 0.01 to 5 times the molar amount of the quinoline carbaldehyde (II) used as a raw material in step 1.
- the same solvent as used in step 1 can be used.
- the amount of the solvent used is preferably in the range of 1 to 50 times by mass the quinoline carbaldehyde (II) used as a raw material in Step 1, and from the viewpoint of economy, it is 1 to 10 times by mass. More preferably, it is within the range.
- the reaction temperature in step 2 varies depending on the type of acid used, the type of solvent, and the like, but is usually preferably in the range of 0 to 100 ° C.
- the reaction time varies depending on the reaction temperature, but is usually preferably in the range of 1 to 24 hours.
- the operation method in step 2 can be performed by mixing the reaction mixture obtained in step 1, water, an acid, and a solvent and stirring the mixture at a predetermined temperature.
- the reaction in step 2 can be performed in either a batch system or a continuous system.
- the quinoline compound (I) thus obtained can be isolated and purified by a method generally used for isolating and purifying organic compounds. For example, if necessary, a base such as aqueous sodium hydrogen carbonate or sodium methoxide is added to the reaction solution after the reaction to neutralize the acid, and then the mixture is treated with an organic solvent such as getyl ether, ethyl acetate, or methylene chloride.
- the crude product obtained by extracting and concentrating the organic layer can be used as it is as an intermediate for the synthesis of pharmaceuticals such as quinoline compounds. If necessary, the purity of the crude product can be further increased by recrystallization, column chromatography or the like.
- a cyclohexenoleamine (24.8 g, 250 mm o 1) was placed in a 200-in-1 three-necked flask equipped with a thermometer, a dropping funnel, and a magnetic stirrer. After cooling, the acetate aldehyde (1.10 g, 250 mmo 1) was added dropwise from the dropping funnel over 2 hours with stirring. After the completion of the dropwise addition, the mixture was further stirred for 2 hours.
- the mixture was allowed to stand, and the organic layer obtained by separating the organic layer and the aqueous layer was distilled under reduced pressure (boiling point: 47 to 48./1.6 kPa), and ethylidenecyclohexynoleamine 125 8 g (206 mmo1, yield 82.5%) was obtained.
- Example 1 1.7 g of ethylidenecyclohexylamine (13.3 g) was used in place of 1,4 g (14.1 mmo1) of ethylidene tert-butylamine.
- Example 2 The same operation as in Example 1 was performed except that 8 mm o 1) was used. A part of the obtained reaction mixture was poured into an aqueous solution of 10% by mass of acetic acid, and the internal standard method was analyzed by high performance liquid chromatography. As a result, it was found that (E) — 3— 1.7 g (5.4 mmo1, yield 78.3%) of 1,2-cyclopropinolequinoline-13'-yl) -open penaldehyde was produced.
- Example 1 In Example 1, except that 1.4 g (14.1 mmo 1) of ethylidene tert-butylamine was used instead of 1.4 g (14.1 mmo 1) of ethylidene n-butylamine, The same operation as in Example 1 was performed. A part of the obtained reaction mixture was poured into a 10% by mass aqueous acetic acid solution, and the internal standard method was analyzed by high performance liquid chromatography. As a result, (E)-3-(4, 1 (4 ") 1.3 g (4.2 mmol, yield 60.3%) of 1,2-cyclopropinolequinoline-1,3-cyclopropynaldehyde) propene aldehyde C
- a quinoline compound useful as a synthetic intermediate for pharmaceuticals and agricultural chemicals for example, quinoline known as an inhibitor of HMG-CoA reductase, which is a rate-limiting enzyme in cholesterol biosynthesis, (E) 13- (4,1 (4,1, fluorophenyl) 12,2-cyclopropylquinoline-13,1yl) propene phenol
- HMG-CoA reductase a rate-limiting enzyme in cholesterol biosynthesis
- E 13- (4,1 (4,1, fluorophenyl) 12,2-cyclopropylquinoline-13,1yl) propene phenol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005505176A JPWO2004089907A1 (ja) | 2003-04-04 | 2004-03-01 | キノリン化合物の製造方法 |
CA002521238A CA2521238A1 (en) | 2003-04-04 | 2004-03-01 | Process for producing quinoline compound |
EP04716036A EP1614682A4 (en) | 2003-04-04 | 2004-03-01 | METHOD FOR PRODUCING A CHINOLINE COMPOUND |
AU2004228485A AU2004228485A1 (en) | 2003-04-04 | 2004-03-01 | Process for producing quinoline compound |
US10/551,777 US20060276653A1 (en) | 2003-04-04 | 2004-03-01 | Process for producing quinoline compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003102134 | 2003-04-04 | ||
JP2003-102134 | 2003-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004089907A1 true WO2004089907A1 (ja) | 2004-10-21 |
Family
ID=33156790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/002464 WO2004089907A1 (ja) | 2003-04-04 | 2004-03-01 | キノリン化合物の製造方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060276653A1 (ja) |
EP (1) | EP1614682A4 (ja) |
JP (1) | JPWO2004089907A1 (ja) |
KR (1) | KR20050111791A (ja) |
CN (1) | CN1768039A (ja) |
AU (1) | AU2004228485A1 (ja) |
CA (1) | CA2521238A1 (ja) |
WO (1) | WO2004089907A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005057077B4 (de) | 2004-11-30 | 2011-04-14 | Hyundai Motor Co. | Vorrichtung zum Scannen von Zuständen von Motoröl |
EP2423195A1 (en) * | 2010-07-26 | 2012-02-29 | LEK Pharmaceuticals d.d. | Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
CN102060761B (zh) * | 2011-01-11 | 2012-10-17 | 浙江大学 | 一种制备喹啉衍生物的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3905908A1 (de) * | 1989-02-25 | 1990-09-06 | Bayer Ag | Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
JP2001316369A (ja) * | 2000-02-21 | 2001-11-13 | Kuraray Co Ltd | キノリン誘導体の製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001232342A1 (en) * | 2000-02-21 | 2001-08-27 | Kuraray Co. Ltd. | Processes for preparing quinoline derivatives and intermediates thereof |
-
2004
- 2004-03-01 JP JP2005505176A patent/JPWO2004089907A1/ja active Pending
- 2004-03-01 US US10/551,777 patent/US20060276653A1/en not_active Abandoned
- 2004-03-01 KR KR1020057018853A patent/KR20050111791A/ko not_active Application Discontinuation
- 2004-03-01 AU AU2004228485A patent/AU2004228485A1/en not_active Abandoned
- 2004-03-01 WO PCT/JP2004/002464 patent/WO2004089907A1/ja active Application Filing
- 2004-03-01 EP EP04716036A patent/EP1614682A4/en not_active Withdrawn
- 2004-03-01 CA CA002521238A patent/CA2521238A1/en not_active Abandoned
- 2004-03-01 CN CNA2004800087245A patent/CN1768039A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3905908A1 (de) * | 1989-02-25 | 1990-09-06 | Bayer Ag | Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
JP2001316369A (ja) * | 2000-02-21 | 2001-11-13 | Kuraray Co Ltd | キノリン誘導体の製造方法 |
Non-Patent Citations (3)
Title |
---|
GAUDEMAR M. ET AL.: "Preparation of (E)-alpha,béta-unsaturated aromatic aldehydes by high stereoselective olefinformylation", TETRAHEDRON LETTERS, vol. 31, no. 3, 1990, pages 349 - 352, XP000095774 * |
MEYERS A.I. ET AL.: "Convenient Preparation of alpha,béta-Unsaturated Aldehydes", J. ORG. CHEM., vol. 43, no. 19, 1978, pages 3788 - 3789, XP002980069 * |
See also references of EP1614682A4 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2004089907A1 (ja) | 2006-07-06 |
EP1614682A1 (en) | 2006-01-11 |
CA2521238A1 (en) | 2004-10-21 |
EP1614682A4 (en) | 2007-12-05 |
CN1768039A (zh) | 2006-05-03 |
US20060276653A1 (en) | 2006-12-07 |
AU2004228485A1 (en) | 2004-10-21 |
KR20050111791A (ko) | 2005-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6949668B2 (en) | Process for producing 5-(3-cyanophenyl)-3-formylbenzoic acid compound | |
US6156925A (en) | Process for the preparation of halogenated phenylmaloates | |
JP5035863B2 (ja) | キノロン抗生物質中間体の調製方法 | |
WO2004089907A1 (ja) | キノリン化合物の製造方法 | |
JP4165858B2 (ja) | tert−アミロキシハロゲノベンゼン化合物とその製法およびtert−アミロキシシアノビフェニル化合物とその製法、並びにシアノヒドロキシビフェニル化合物の製法 | |
EP1262476B1 (en) | Processes for preparing quinoline derivatives and intermediates thereof | |
CN112851652B (zh) | 一种2-(取代氧杂蒽基)苯并呋喃类化合物的催化氧化合成方法 | |
JP4176201B2 (ja) | 5−ハロゲノ−2−置換ピリジンの製造方法 | |
US5247124A (en) | Process for the preparation of substituted styrenes | |
JP4867071B2 (ja) | キノリン誘導体の製造方法 | |
WO2005095317A1 (ja) | ハロゲン化不飽和カルボニル化合物の製造方法 | |
US6815559B2 (en) | Process for producing 3,3,3-trifluoro-2-hydroxypropionic acid or its derivative | |
KR100735587B1 (ko) | 퀴놀론계 항생제 중간체의 제조 방법 | |
JP4667589B2 (ja) | 2,4−ジヒドロキシピリジンの製造方法 | |
JP3820827B2 (ja) | ケトンの製法 | |
JP2000344722A (ja) | 4−ヒドロキシメチル−1−アミノシクロペント−2−エン誘導体の製造方法 | |
FR2696746A1 (fr) | Dérivés de l'acide benzèneborinique, leur préparation et leur utilisation comme intermédiaires de synthèse. | |
JP4663105B2 (ja) | 2−スルホニル−4−オキシピリジン誘導体の製造方法 | |
JP2001172274A (ja) | 4−アセチルテトラヒドロピランの製法 | |
JP3864657B2 (ja) | 芳香族アクリロニトリルの製造法 | |
US6291696B2 (en) | Preparation of tris (trimethylsilyl) silylethyl esters | |
JP2009143885A (ja) | アセトフェノン誘導体の製造法 | |
JP2004331515A (ja) | 3−アセトキシスチレンの製造方法 | |
JP2002308815A (ja) | ラバンジュラールの製造方法 | |
US5210278A (en) | Process for the preparation of bisarylalkyl ethers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005505176 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 171021 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048087245 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004228485 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006276653 Country of ref document: US Ref document number: 2521238 Country of ref document: CA Ref document number: 10551777 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057018853 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2004228485 Country of ref document: AU Date of ref document: 20040301 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004228485 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004716036 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2856/CHENP/2005 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057018853 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004716036 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10551777 Country of ref document: US |